Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Akriveia Therapeutics
23 Southern Hills Drive
Skillman, NJ 08558
Phone: 609-560-0927
http://www.akriveiatx.com/

Akriveia Therapeutics is discovering and developing the next generation of cancer immunotherapies. Akriveia's new agents offer the promise of a safer and more efficacious approach to harness a patient's own immune system to fight cancer. Akriveia was founded on the pioneering work of Professor John Williams at City of Hope and Professor Ulrich Rodeck at Thomas Jefferson University, experts in the fields of bioengineering and cancer therapeutic discovery.

Key Contact
Name
Simon Tomlinson
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
10/12/16 $7,500,000 Series A F-Prime Capital Partners
undisclosed


Featured Reading